Deerfield Management Company as of Sept. 30, 2018
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 103 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Horizon Pharma | 4.6 | $129M | 6.6M | 19.58 | |
Homology Medicines | 4.3 | $120M | 5.2M | 22.86 | |
Horizon Pharma Plc convertible security | 3.5 | $99M | 99M | 1.00 | |
Nevro Corp note 1.750% 6/0 | 3.5 | $99M | 100M | 0.99 | |
Aerie Pharmaceuticals | 3.4 | $95M | 1.5M | 61.55 | |
Dexcom Inc dbcv 0.750% 5/1 | 3.0 | $84M | 55M | 1.53 | |
Mylan Nv | 2.4 | $67M | 1.8M | 36.60 | |
Portola Pharmaceuticals | 2.3 | $65M | 2.5M | 26.63 | |
Dbv Technologies S A | 2.3 | $65M | 2.9M | 22.46 | |
Anaptysbio Inc Common (ANAB) | 2.3 | $65M | 648k | 99.77 | |
Acceleron Pharma | 2.3 | $64M | 1.1M | 57.23 | |
Endocyte | 2.2 | $62M | 3.5M | 17.76 | |
Intersect Ent | 2.2 | $62M | 2.1M | 28.75 | |
Myokardia | 2.1 | $60M | 917k | 65.20 | |
BioCryst Pharmaceuticals (BCRX) | 1.9 | $53M | 6.9M | 7.63 | |
Acadia Healthcare (ACHC) | 1.8 | $50M | 1.4M | 35.20 | |
Argenx Se (ARGX) | 1.8 | $50M | 657k | 75.84 | |
Kempharm Inc note 5.500% 2/0 | 1.7 | $48M | 75M | 0.64 | |
Sarepta Therapeutics (SRPT) | 1.7 | $48M | 296k | 161.51 | |
Brookdale Senior Living (BKD) | 1.7 | $46M | 4.7M | 9.83 | |
Wright Medical Group Nv 2.25 20211115 | 1.6 | $46M | 32M | 1.45 | |
Aclaris Therapeutics (ACRS) | 1.6 | $45M | 3.1M | 14.52 | |
CVS Caremark Corporation (CVS) | 1.6 | $45M | 567k | 78.72 | |
Xeris Pharmaceuticals | 1.6 | $44M | 2.5M | 17.58 | |
Blueprint Medicines (BPMC) | 1.5 | $41M | 525k | 78.06 | |
Mirati Therapeutics | 1.4 | $40M | 841k | 47.10 | |
Glaukos (GKOS) | 1.3 | $37M | 569k | 64.90 | |
Editas Medicine (EDIT) | 1.3 | $37M | 1.2M | 31.82 | |
Intercept Pharmas conv | 1.3 | $36M | 36M | 1.01 | |
Centene Corporation (CNC) | 1.3 | $36M | 245k | 144.78 | |
eHealth (EHTH) | 1.2 | $35M | 1.2M | 28.26 | |
Universal Health Services (UHS) | 1.2 | $34M | 262k | 127.84 | |
Immunomedics | 1.2 | $33M | 1.6M | 20.83 | |
Nevro (NVRO) | 1.1 | $30M | 525k | 57.00 | |
K2m Group Hldgs Inc bond | 1.1 | $30M | 20M | 1.50 | |
Galapagos Nv- (GLPG) | 1.1 | $29M | 260k | 112.43 | |
Select Medical Holdings Corporation (SEM) | 1.0 | $28M | 1.5M | 18.40 | |
Kiniksa Pharmaceuticals | 1.0 | $27M | 1.1M | 25.50 | |
Agios Pharmaceuticals (AGIO) | 1.0 | $27M | 348k | 77.12 | |
Anthem (ELV) | 0.9 | $26M | 95k | 274.05 | |
Dfb Healthcare Acquistion Co unit 01/30/2023 | 0.9 | $26M | 2.5M | 10.20 | |
Reata Pharmaceuticals Inc Cl A | 0.9 | $24M | 294k | 81.76 | |
Vericel (VCEL) | 0.8 | $23M | 1.6M | 14.15 | |
Ascendis Pharma A S (ASND) | 0.8 | $23M | 320k | 70.86 | |
Arvinas Ord (ARVN) | 0.8 | $21M | 1.2M | 16.87 | |
Regenxbio Inc equity us cm (RGNX) | 0.7 | $21M | 275k | 75.50 | |
Audentes Therapeutics | 0.7 | $20M | 494k | 39.59 | |
Synlogic | 0.7 | $19M | 1.4M | 14.21 | |
Fate Therapeutics (FATE) | 0.7 | $19M | 1.2M | 16.29 | |
Epizyme | 0.7 | $19M | 1.8M | 10.60 | |
Oxford Immunotec Global | 0.6 | $18M | 1.1M | 16.23 | |
Diplomat Pharmacy | 0.6 | $17M | 854k | 19.41 | |
Zimmer Holdings (ZBH) | 0.6 | $16M | 121k | 131.47 | |
Morphosys (MOR) | 0.6 | $16M | 600k | 26.70 | |
Ardelyx (ARDX) | 0.5 | $15M | 3.5M | 4.35 | |
Aimmune Therapeutics | 0.5 | $15M | 553k | 27.28 | |
Syros Pharmaceuticals | 0.5 | $15M | 1.3M | 11.91 | |
G1 Therapeutics | 0.5 | $15M | 287k | 52.29 | |
Cymabay Therapeutics | 0.5 | $15M | 1.3M | 11.08 | |
Aac Holdings | 0.5 | $14M | 1.9M | 7.63 | |
Sientra | 0.5 | $14M | 594k | 23.88 | |
Kalvista Pharmaceuticals (KALV) | 0.5 | $14M | 650k | 22.11 | |
Cytomx Therapeutics (CTMX) | 0.5 | $14M | 730k | 18.50 | |
Flamel Technologies Sa | 0.4 | $12M | 2.7M | 4.39 | |
Tandem Diabetes Care (TNDM) | 0.4 | $12M | 283k | 42.84 | |
Invitae (NVTAQ) | 0.4 | $12M | 688k | 16.73 | |
Rhythm Pharmaceuticals (RYTM) | 0.4 | $11M | 366k | 29.17 | |
Nightstar Therapeutics | 0.4 | $10M | 500k | 20.43 | |
Teligent Inc New bond | 0.4 | $10M | 9.6M | 1.09 | |
Allakos (ALLK) | 0.4 | $10M | 225k | 44.99 | |
Melinta Therapeutics | 0.3 | $9.1M | 2.3M | 3.95 | |
Bluebird Bio (BLUE) | 0.3 | $9.0M | 61k | 146.01 | |
Livanova Plc Ord (LIVN) | 0.3 | $8.9M | 72k | 123.97 | |
Nuvasive Inc note 2.250% 3/1 | 0.3 | $8.9M | 7.0M | 1.27 | |
Biohaven Pharmaceutical Holding | 0.3 | $9.0M | 239k | 37.55 | |
Uniqure Nv (QURE) | 0.3 | $8.8M | 241k | 36.39 | |
Karyopharm Therapeutics (KPTI) | 0.3 | $8.1M | 475k | 17.03 | |
Viking Therapeutics (VKTX) | 0.3 | $8.0M | 460k | 17.42 | |
Inspire Med Sys (INSP) | 0.3 | $8.0M | 189k | 42.08 | |
Autolus Therapeutics Plc spon ads (AUTL) | 0.3 | $7.7M | 250k | 30.67 | |
Ra Pharmaceuticals | 0.2 | $6.9M | 383k | 18.09 | |
Rocket Pharmaceuticals (RCKT) | 0.2 | $6.9M | 280k | 24.62 | |
Nuvectra | 0.2 | $6.1M | 279k | 21.98 | |
Alimera Sciences | 0.2 | $5.9M | 6.1M | 0.98 | |
Pfenex | 0.2 | $5.5M | 1.1M | 5.11 | |
Gw Pharmaceuticals Plc ads | 0.2 | $5.1M | 29k | 172.72 | |
Addus Homecare Corp (ADUS) | 0.2 | $4.6M | 66k | 70.15 | |
Eidos Therapeutics | 0.1 | $4.2M | 420k | 9.98 | |
Constellation Pharmceticls I | 0.1 | $4.3M | 636k | 6.73 | |
Albireo Pharma | 0.1 | $4.0M | 120k | 32.96 | |
Alpine Immune Sciences | 0.1 | $3.9M | 613k | 6.33 | |
Teligent Inc note 3.750 12/1 | 0.1 | $3.5M | 3.7M | 0.95 | |
BioScrip | 0.1 | $3.2M | 1.0M | 3.10 | |
Teligent | 0.1 | $2.8M | 709k | 3.95 | |
Savara (SVRA) | 0.1 | $2.8M | 250k | 11.16 | |
Proteon Therapeutics | 0.1 | $2.4M | 1.2M | 1.95 | |
Voyager Therapeutics (VYGR) | 0.1 | $2.2M | 118k | 18.92 | |
Orthopediatrics Corp. (KIDS) | 0.1 | $2.1M | 58k | 36.64 | |
Ra Med Sys | 0.1 | $2.3M | 129k | 18.20 | |
Foamix Pharmaceuticals | 0.1 | $1.3M | 235k | 5.73 | |
Eyenovia Inc equity (EYEN) | 0.0 | $1.2M | 300k | 4.02 | |
Pernix Therapeutics Holdings | 0.0 | $633k | 659k | 0.96 | |
Histogenics Corp Cmn | 0.0 | $160k | 296k | 0.54 |